BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34950756)

  • 1. Data on the effects of ECM rigidity on actomyosin contractility and invadopodia activity in individual versus pairs of head and neck squamous cell carcinoma cells.
    Jerrell R; Leih M; Parekh A
    Data Brief; 2022 Feb; 40():107684. PubMed ID: 34950756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular traction stresses mediate extracellular matrix degradation by invadopodia.
    Jerrell RJ; Parekh A
    Acta Biomater; 2014 May; 10(5):1886-96. PubMed ID: 24412623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix rigidity differentially regulates invadopodia activity through ROCK1 and ROCK2.
    Jerrell RJ; Parekh A
    Biomaterials; 2016 Apr; 84():119-129. PubMed ID: 26826790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyacrylamide gels for invadopodia and traction force assays on cancer cells.
    Jerrell RJ; Parekh A
    J Vis Exp; 2015 Jan; (95):52343. PubMed ID: 25590238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Data on the negative regulation of invadopodia activity by MLCK.
    Jerrell RJ; Parekh A
    Data Brief; 2019 Jun; 24():103939. PubMed ID: 31111082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of human papillomavirus oncoproteins E6 and E7 inhibits invadopodia activity but promotes cell migration in HPV-positive head and neck squamous cell carcinoma cells.
    Kahue CN; Jerrell RJ; Parekh A
    Cancer Rep (Hoboken); 2018 Oct; 1(3):e1125. PubMed ID: 32721084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular matrix rigidity promotes invadopodia activity.
    Alexander NR; Branch KM; Parekh A; Clark ES; Iwueke IC; Guelcher SA; Weaver AM
    Curr Biol; 2008 Sep; 18(17):1295-1299. PubMed ID: 18718759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct measurement of vertical forces shows correlation between mechanical activity and proteolytic ability of invadopodia.
    Dalaka E; Kronenberg NM; Liehm P; Segall JE; Prystowsky MB; Gather MC
    Sci Adv; 2020 Mar; 6(11):eaax6912. PubMed ID: 32195338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function.
    Artym VV; Zhang Y; Seillier-Moiseiwitsch F; Yamada KM; Mueller SC
    Cancer Res; 2006 Mar; 66(6):3034-43. PubMed ID: 16540652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of invadopodia by mechanical signaling.
    Parekh A; Weaver AM
    Exp Cell Res; 2016 Apr; 343(1):89-95. PubMed ID: 26546985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DCLK1-Mediated Regulation of Invadopodia Dynamics and Matrix Metalloproteinase Trafficking Drives Invasive Progression in Head and Neck Squamous Cell Carcinoma.
    Arnold L; Yap M; Jackson L; Barry M; Ly T; Morrison A; Gomez JP; Washburn MP; Standing D; Yellapu NK; Li L; Umar S; Anant S; Thomas SM
    bioRxiv; 2024 Apr; ():. PubMed ID: 38645056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia.
    Clark ES; Whigham AS; Yarbrough WG; Weaver AM
    Cancer Res; 2007 May; 67(9):4227-35. PubMed ID: 17483334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of cancer invasiveness by the physical extracellular matrix environment.
    Parekh A; Weaver AM
    Cell Adh Migr; 2009; 3(3):288-92. PubMed ID: 19458499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic membrane remodeling at invadopodia differentiates invadopodia from podosomes.
    Artym VV; Matsumoto K; Mueller SC; Yamada KM
    Eur J Cell Biol; 2011; 90(2-3):172-80. PubMed ID: 20656375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-375 Suppresses Extracellular Matrix Degradation and Invadopodial Activity in Head and Neck Squamous Cell Carcinoma.
    Jimenez L; Sharma VP; Condeelis J; Harris T; Ow TJ; Prystowsky MB; Childs G; Segall JE
    Arch Pathol Lab Med; 2015 Nov; 139(11):1349-61. PubMed ID: 26172508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invadopodia formation in oral squamous cell carcinoma: the role of epidermal growth factor receptor signalling.
    Hwang YS; Park KK; Chung WY
    Arch Oral Biol; 2012 Apr; 57(4):335-43. PubMed ID: 21920495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic and tissue-derived models for studying rigidity effects on invadopodia activity.
    Weaver AM; Page JM; Guelcher SA; Parekh A
    Methods Mol Biol; 2013; 1046():171-89. PubMed ID: 23868588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invadopodia: at the cutting edge of tumour invasion.
    Stylli SS; Kaye AH; Lock P
    J Clin Neurosci; 2008 Jul; 15(7):725-37. PubMed ID: 18468901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invadopodia: the leading force.
    Sibony-Benyamini H; Gil-Henn H
    Eur J Cell Biol; 2012; 91(11-12):896-901. PubMed ID: 22633185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting SNARE-Mediated Vesicle Transport to Block Invadopodium-Based Cancer Cell Invasion.
    Gorshtein G; Grafinger O; Coppolino MG
    Front Oncol; 2021; 11():679955. PubMed ID: 34094984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.